Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance - Wikidata - wikimedia - TriplyDB

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

http://www.wikidata.org/entity/Q37066869

about

Insulin receptor signaling in normal and insulin-resistant states The human plasma lipidome Podocyte pathology and nephropathy - sphingolipids in glomerular diseases On ceramides, other sphingolipids and impaired glucose homeostasis The adipokine/ceramide axis: key aspects of insulin sensitization Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: A Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJ Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.Lipidomic analyses in epidemiology.Evaluation of the photooxidation of galactosyl- and lactosylceramide by electrospray ionization mass spectrometry.Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery.Detection of Independent Associations of Plasma Lipidomic Parameters with Insulin Sensitivity Indices Using Data Mining Methodology Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance.Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease.Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes Insulin increases ceramide synthesis in skeletal muscle Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in cultured myotubes.Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 Sphingolipids in obesity, type 2 diabetes, and metabolic disease.Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study Distinct gene expression profiles characterize cellular responses to palmitate and oleate.Antihypertensive treatment differentially affects vascular sphingolipid biology in spontaneously hypertensive rats Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.Ceramides and glucosylceramides are independent antagonists of insulin signaling Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice.Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia Plasma sphingosine-1-phosphate is elevated in obesity Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes.PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 3.Plasma phospholipids, non-esterified plasma polyunsaturated fatty acids and oxylipids are associated with BMI.

P2860

Q26823171-242760C7-A926-4267-AC7C-410C8E26A175 Q26830940-A0B26F97-5224-407A-9CFF-50C9C879A102 Q26852463-B08D5F61-A496-44F7-9025-1CB35E6E944C Q27021446-4C1096DE-AAB4-4DA5-912E-6E28E1D20FF9 Q27025041-89129F83-EBA4-434F-83D3-8318C907FEE6 Q28364529-C97993B9-4023-49C9-B5EB-1BC301796C1E Q28547365-5DEDD60D-1F76-4365-B6B7-CE7E3D92EE7B Q30241943-6BEC796A-0CEE-44D1-8F48-3A95F94611A1 Q30249688-C299B420-B802-4399-A41B-3560A1D192AE Q30857220-FCDD6F22-D2EF-4322-B322-47B5F5644334 Q30913648-E18523DE-8419-45C5-8133-58C9BE3C7239 Q31136458-F60F4E36-3047-4B77-86B1-6C8C3FF21FB3 Q33580624-8B0FC805-3E2E-41F5-AF0F-82B57495B610 Q33587148-688839E5-354F-4A10-88BB-F21DEACD6DEB Q33616876-500A851F-03B7-4393-9B72-579732879941 Q33726611-FD5D0FE2-AF8D-4D22-B75B-C6142B484E6B Q33736297-7BB787E2-380E-48FE-91FF-FFE307A4D9BD Q33752866-70332DAF-DCE5-462F-9BBA-ED913E192D50 Q33825102-2FE85A1E-F862-489E-9421-E035DF13A9D4 Q33857979-8F4A3BB3-8921-4F7B-BEB3-293F7AD0E8BF Q33880303-A08B9763-240D-47D6-A8B0-470DBA32173D Q33880588-796F1C7D-A68E-44ED-B19E-6ABE4C20FE9F Q33896092-F858922C-C0F2-4D37-98C9-C6F4DAE7815B Q33993213-2A7A8D84-7946-4CAC-A4D0-F78786C75CDD Q34110842-ADC80386-6491-4A3E-8FD0-B782F74423DB Q34132356-5A1B298C-A6B0-4C07-91CE-319BF0DCBEE3 Q34178121-36E44D53-CCE1-431F-A6F8-D663802B757B Q34358476-850B689A-EB05-493A-B35A-6E43A1A05A4D Q34384118-6669093C-B47D-4B2D-9051-43796EA2E826 Q34469234-20ED4F28-0314-469D-BD51-9F4635E1C213 Q34485836-4F413AB0-BC8F-4861-ABFF-EA3AB955031C Q34527732-FA206F15-DA84-4FD7-8D23-ED7D3AF160B4 Q34569354-9A5D1581-39A0-48DC-A479-73F81E384451 Q34608259-E343155D-6B85-4173-83B4-44984F07A55D Q34988407-098B5BC6-09FA-4D4B-92B9-8EDAAD451132 Q35004985-13DF9EAD-4929-4B2E-85BA-DCA7C0E0D70C Q35014728-34160FD6-BD79-40DA-B063-BF05EEB36918 Q35060608-E049A271-C92E-4FC2-9BCF-77C393CA7F0C Q35179847-49D95105-307E-4115-AFF0-650172574593 Q35181326-38F52382-0074-4CE8-9568-2860966E4B9C

P2860

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

http://www.wikidata.org/entity/Q37066869

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Plasma ceramides are elevated ...... severity of insulin resistance

@en

Plasma ceramides are elevated ...... everity of insulin resistance.

@nl

type

label

Plasma ceramides are elevated ...... severity of insulin resistance

@en

Plasma ceramides are elevated ...... everity of insulin resistance.

@nl

prefLabel

Plasma ceramides are elevated ...... severity of insulin resistance

@en

Plasma ceramides are elevated ...... everity of insulin resistance.

@nl

P1433

Q37066869-317904A6-8547-4562-83FB-A354F3C411BC

P1476

Q37066869-B395FEBF-B071-40DD-AF7C-E037AEC96180

P2093

Q37066869-03FEE7F6-FA2F-4593-B6CC-1707F743E45C

Q37066869-0B139BDB-ACC2-40F7-8D29-3BAFDE341EB8

Q37066869-56D28005-491D-4E5A-B6C0-D34AC17C8319

Q37066869-649E74B1-DA3B-4B47-89C4-D4CBC3C04576

Q37066869-A626BE92-DAA3-4926-9397-4168200DC3C5

Q37066869-BD2DB2A2-EC25-417C-9ED6-FA8CE9C26E51

Q37066869-CF047A9C-1F42-457F-B06E-CF026062EAB4

P2860

Q37066869-03300707-EC81-4C21-BB1D-BDDA0A290CC5

Q37066869-04A89343-D807-425E-A044-B3A90A22F5F7

Q37066869-0861681C-5DC0-4A0C-9BA6-F83941AFFE20

Q37066869-0C93F7E7-FBD2-4236-9E3B-BF4E80A46123

Q37066869-2458AA8E-E9F0-4E6D-96C7-9CB1E4E76766

Q37066869-2C41A48E-47C0-43D6-AE02-1FC087AC1104

Q37066869-2F5B2E5D-57F6-43E8-9E03-4253F73254B5

Q37066869-31103CAB-C4FF-4956-9546-220EBE5BBA56

Q37066869-313BE3EF-A704-43B0-ADFB-34A46CF3D68A

Q37066869-329F74AC-4F82-4CE3-84F9-5DE73A87C2DC

P304

Q37066869-2C30A400-974A-4CAC-B013-8A022E0E3C9B

P31

Q37066869-26A7B84A-74F0-49DE-8EE7-423C5D57C5B8

P356

Q37066869-E20CC81F-19A3-4305-BEB9-DC646D553D67

P407

Q37066869-51293013-D7DA-48CC-A03A-2038E0ECF69D

P433

Q37066869-DB1D4EF7-2A39-436F-B99D-59634C4EC980

P478

Q37066869-27128533-A42E-419A-BB64-D6B505C4219C

P577

Q37066869-D3BB70DD-5587-4727-9185-B42265A7A83E

P5875

Q37066869-8BDBA7F4-E2FB-46D0-8B0F-6DCD3985B341

P698

Q37066869-AFE3E6E6-5CFA-4268-BBC5-8016AE87FB0F

P921

Q37066869-66175E4E-0EC4-4947-8705-C7E1CEA4B29E

Q37066869-DFE1C7AA-5EC2-4FAB-A341-72733734C0EE

P932

Q37066869-18CDD72F-3C1B-4ABA-A68D-CB4394E4DDC7

P356

P1433

P1476

Plasma ceramides are elevated ...... severity of insulin resistance

@en

P2093

Jacob M Haus

http://www.w3.org/2001/XMLSchema#string

John P Kirwan

http://www.w3.org/2001/XMLSchema#string

Karen R Kelly

http://www.w3.org/2001/XMLSchema#string

Ralph A Defronzo

http://www.w3.org/2001/XMLSchema#string

Renliang Zhang

http://www.w3.org/2001/XMLSchema#string

Sangeeta R Kashyap

http://www.w3.org/2001/XMLSchema#string

Takhar Kasumov

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation, stress, and diabetes

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis

Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis.

Physiology and pathophysiology of sphingolipid metabolism and signaling.

Metabolism of sphingomyelin in the intestinal tract of the rat.

Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Pathogenesis of type 2 diabetes mellitus.

Dysfunctional fat cells, lipotoxicity and type 2 diabetes.

P304

337-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1228

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23472727

http://www.w3.org/2001/XMLSchema#string

P698

19008343

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2628606

http://www.w3.org/2001/XMLSchema#string